What is Precision Medicine Group's business focus and history?
Precision Medicine Group is a private company based in Bethesda, Maryland, founded in 2012 by Ethan Leder and Mark Clein. It operates as a specialized services company supporting next-generation approaches to drug development and commercialization. Precision Medicine Group has raised significant funding, including a $275 million investment in December 2017 co-led by Berkshire Partners and TPG Growth, and a major investment from Blackstone in November 2020. The company has over 3,500 employees and offices throughout North America, Europe, and Asia.
Precision Medicine Group Corporate Details & Core Services
Precision Medicine Group is a specialized services company supporting next-generation approaches to drug development and commercialization. They provide an integrated infrastructure that supports pharmaceutical and life sciences companies as they develop new products in the age of precision medicine.
Precision Medicine Group Contact Information & Official Links
Drug DevelopmentCommercialization ServicesLife SciencesPharmaceutical ServicesPrecision Medicine
What are Precision Medicine Group's Key Business Metrics & Stats?
No of employees
3500
Founded year
2012
Type
private
Industry
Pharmaceutical Services
Location
Bethesda, Maryland, United States
How much funding has Precision Medicine Group raised to date?
Name
Description
Funding Amount
USD 150 Million
Stage
Private Equity
Latest Valuation
(USD)
Investors
Oak Investment Partners, J.H. Whitney and Company, LCI Capital
What are Precision Medicine Group's Core Products?
Name
Description
Precision for Medicine
Provides biomarker-driven research and development services, including global CRO, specialty labs, and biospecimens.
Precision AQ
Offers commercialization services such as commercial consulting, health economics and outcomes research (HEOR), market access marketing, and medical communications.
What are the latest developments at Precision Medicine Group?
Date
Type
Description
November, 2020
Investment
Precision Medicine Group secures major investment from Blackstone.
January, 2021
Acquisition
Precision Medicine Group acquires Project Farma to expand cell and gene therapy expertise.
October, 2024
Leadership Appointment
Precision Medicine Group announces key leadership appointments, including Karl Deonanan as CFO.
What are Precision Medicine Group's official legal and registration details?
Name
Description
Legal Name
Precision Medicine Group
Cin number
GST number
Registration number
Who is in Precision Medicine Group's executive leadership team?
Name
Designation
CEO
Margaret Keegan
Chief Financial Officer
Karl Deonanan
Chief Transformation and Strategy Officer
Matt DeZee
Chief People Officer
Tracey Leahy
Where are Precision Medicine Group's primary office locations?
City
Country
Bethesda
United States
Frederick
United States
Gaithersburg
United States
Boston
United States
Costa Mesa
United States
San Jose
United States
Seattle
United States
Toronto
Canada
London
United Kingdom
Paris
France
Berlin
Germany
Shanghai
China
What are the current business signals and market intelligence for Precision Medicine Group?
Type of customer
Pharmaceutical Companies, Biotechnology Firms, Life Sciences Organizations
Key customer domain
What are Precision Medicine Group's risk management and compliance ratings?
GDPR RIsk
No
Privacy Risk
No
Company Ratings
Glassdoor Rating
What are Precision Medicine Group's business model and service classifications?
